Flu vaccine study for healthy children
Part of Infections, Lungs & breathing clinical trials.
This study tests an experimental flu vaccine in healthy children and teens to see if it is safe and how well it works. It may help protect against flu and is given as one or more shots.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 9 to less than 18 years old.
- You must be in good general health with no unstable medical conditions.
- If you are a female who could become pregnant, you need a negative pregnancy test and agree to use birth control or abstain from pregnancy-related activities for a certain time.
- You must not have had a severe allergic reaction to any mRNA vaccine, flu vaccine, or eggs.
- You must not be acutely ill or have a fever (100.4°F or higher) within 72 hours before the study visit.
- You must not have received certain immune-suppressing medications or blood products recently, and you must wait before getting other vaccines.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational flu vaccine (FluMos-v2) with or without an adjuvant (ALFQ) to see how safe, tolerable, and effective it is. It may help protect against multiple flu strains.
This study tests a new flu vaccine to see how well it protects adults aged 18 to 64. If you join, you'll get the vaccine and have some check-ups to see how your body responds.
This study tests an investigational flu vaccine to see how well it protects against seasonal flu. It is for people ages 3 and older who have had a flu shot in the past year (for children ages 3–8) or have not had one recently (for ages 9+). The study will last several months and involves a few clinic visits.
This study tests a new flu vaccine in adults aged 65 and older to see how well it prevents the flu. If you are generally healthy or manage chronic conditions well, you may be able to join.
This trial is testing a new mRNA-based flu vaccine in healthy adults. It aims to see if the vaccine is safe and effective at preventing influenza.
This trial tests new mRNA-based flu vaccines that may provide broader protection against different flu strains. Participants will receive the vaccine and be monitored for safety and their immune response.
Hear when a new Seasonal Influenza trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.